ARQ vs. WLKP, ASIX, ASPI, OEC, VHI, LXFR, ADUR, VGAS, AMTX, and LODE
Should you be buying ARQ stock or one of its competitors? The main competitors of ARQ include Westlake Chemical Partners (WLKP), AdvanSix (ASIX), ASP Isotopes (ASPI), Orion (OEC), Valhi (VHI), Luxfer (LXFR), Aduro Clean Technologies (ADUR), Verde Clean Fuels (VGAS), Aemetis (AMTX), and Comstock (LODE). These companies are all part of the "chemicals" industry.
ARQ vs. Its Competitors
ARQ (NASDAQ:ARQ) and Westlake Chemical Partners (NYSE:WLKP) are both small-cap chemicals companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.
In the previous week, Westlake Chemical Partners had 1 more articles in the media than ARQ. MarketBeat recorded 2 mentions for Westlake Chemical Partners and 1 mentions for ARQ. Westlake Chemical Partners' average media sentiment score of 0.34 beat ARQ's score of -0.59 indicating that Westlake Chemical Partners is being referred to more favorably in the news media.
ARQ has a beta of 1.7, suggesting that its stock price is 70% more volatile than the S&P 500. Comparatively, Westlake Chemical Partners has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500.
Westlake Chemical Partners has a net margin of 4.82% compared to ARQ's net margin of -1.30%. Westlake Chemical Partners' return on equity of 6.35% beat ARQ's return on equity.
ARQ presently has a consensus target price of $9.00, suggesting a potential upside of 50.88%. Given ARQ's higher probable upside, equities research analysts plainly believe ARQ is more favorable than Westlake Chemical Partners.
18.5% of ARQ shares are owned by institutional investors. Comparatively, 78.3% of Westlake Chemical Partners shares are owned by institutional investors. 23.9% of ARQ shares are owned by insiders. Comparatively, 1.1% of Westlake Chemical Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Westlake Chemical Partners has higher revenue and earnings than ARQ. ARQ is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.
Summary
Westlake Chemical Partners beats ARQ on 11 of the 16 factors compared between the two stocks.
Get ARQ News Delivered to You Automatically
Sign up to receive the latest news and ratings for ARQ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ARQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NASDAQ:ARQ) was last updated on 7/7/2025 by MarketBeat.com Staff
